ALTME:EPA
TME Pharma NV
€0.11
arrow_upward
+2.05%(+0.0022) 1D
Sep 11, 5:35:20 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALTME...
Open
€0.10
High
€0.11
Low
€0.10
Mkt. cap
10.29M
Avg. vol.
4.06M
Volume
2.11M
52-wk high
€0.17
52-wk low
€0.05
EPS
-€0.03
No. of employees
0
Open
€0.10
High
€0.11
Low
€0.10
Mkt. cap
10.29M
Avg. vol.
4.06M
Volume
2.11M
52-wk high
€0.17
52-wk low
€0.05
EPS
-€0.03
No. of employees
0
Profile
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
About TME Pharma NV